Diamond Biofund (6901.TW) Earnings Analysis
Diamond Biofund (6901.TW) next reports earnings on 2026-08-07, consensus EPS -1.08 TWD. It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -15.21.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6901.TW next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | -1.08 TWD |
| Revenue estimate | n/a |
6901.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-04 | -0.0172 TWD | n/a | n/a | n/a |
| 2025-11-10 | -0.17 TWD | n/a | n/a | n/a |
| 2025-06-30 | -0.52 TWD | n/a | n/a | n/a |
| 2024-12-31 | -0.89661 TWD | 0.44 TWD | -303.8% | Miss |
| 2024-09-30 | -0.95 TWD | 0.38 TWD | -350% | Miss |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
6901.TW valuation and analyst view
| Trailing P/E | -15.21 |
|---|---|
| Trailing EPS | -1.12532 TWD |
| Price / book | 1.65 |
| Dividend yield | 0.00% |
| Market cap | 14.93B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Diamond Biofund (6901.TW)'s next earnings date?
Diamond Biofund is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -1.08 TWD.
Did 6901.TW beat earnings last quarter?
Consensus estimate data was not available for 6901.TW's 2026-03-04 report.
What is 6901.TW's earnings track record?
Over the last 2 reported quarters with consensus data, 6901.TW beat estimates 0 times (0%).
What is 6901.TW's current P/E ratio and EPS?
6901.TW trades at a trailing P/E of -15.21 on trailing EPS of -1.1253171948948626 TWD.
What do analysts rate 6901.TW?
6901.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.